List of Excipients in API nystatin and triamcinolone acetonide
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing nystatin and triamcinolone acetonide
Detailed excipient profiles for nystatin and triamcinolone acetonide
Excipient focus: ALGELDRATE
nystatin and triamcinolone acetonide drug variants containing ALGELDRATE
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | nystatin and triamcinolone acetonide | 0168-0081 |
| >Company | >Ingredient | >NDC |
nystatin and triamcinolone acetonide drug variants not containing ALGELDRATE
Excipient focus: ALUMINUM HYDROXIDE
nystatin and triamcinolone acetonide drug variants containing ALUMINUM HYDROXIDE
nystatin and triamcinolone acetonide drug variants not containing ALUMINUM HYDROXIDE
Excipient focus: BENZYL ALCOHOL
nystatin and triamcinolone acetonide drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | nystatin and triamcinolone acetonide | 0168-0081 |
| >Company | >Ingredient | >NDC |
nystatin and triamcinolone acetonide drug variants not containing BENZYL ALCOHOL
Excipient focus: CETEARETH-15
nystatin and triamcinolone acetonide drug variants containing CETEARETH-15
nystatin and triamcinolone acetonide drug variants not containing CETEARETH-15
Excipient focus: CETOSTEARYL ALCOHOL
nystatin and triamcinolone acetonide drug variants containing CETOSTEARYL ALCOHOL
nystatin and triamcinolone acetonide drug variants not containing CETOSTEARYL ALCOHOL
Excipient focus: CETYL PALMITATE
nystatin and triamcinolone acetonide drug variants containing CETYL PALMITATE
| Company | Ingredient | NDC |
|---|---|---|
| Crown Laboratories | nystatin and triamcinolone acetonide | 0316-0223 |
| REMEDYREPACK INC | nystatin and triamcinolone acetonide | 70518-2935 |
| >Company | >Ingredient | >NDC |
nystatin and triamcinolone acetonide drug variants not containing CETYL PALMITATE
Excipient focus: DIMETHICONE
nystatin and triamcinolone acetonide drug variants containing DIMETHICONE
nystatin and triamcinolone acetonide drug variants not containing DIMETHICONE
Excipient focus: GLYCERYL MONO AND DIPALMITOSTEARATE
nystatin and triamcinolone acetonide drug variants containing GLYCERYL MONO AND DIPALMITOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Inc | nystatin and triamcinolone acetonide | 62332-606 |
| Aleor Dermaceuticals Limited | nystatin and triamcinolone acetonide | 71589-012 |
| >Company | >Ingredient | >NDC |
nystatin and triamcinolone acetonide drug variants not containing GLYCERYL MONO AND DIPALMITOSTEARATE
Excipient focus: GLYCERYL MONOSTEARATE
nystatin and triamcinolone acetonide drug variants containing GLYCERYL MONOSTEARATE
nystatin and triamcinolone acetonide drug variants not containing GLYCERYL MONOSTEARATE
Excipient focus: HIGH DENSITY POLYETHYLENE
nystatin and triamcinolone acetonide drug variants containing HIGH DENSITY POLYETHYLENE
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | nystatin and triamcinolone acetonide | 0168-0089 |
| >Company | >Ingredient | >NDC |
nystatin and triamcinolone acetonide drug variants not containing HIGH DENSITY POLYETHYLENE
Excipient focus: LOW DENSITY POLYETHYLENE
nystatin and triamcinolone acetonide drug variants containing LOW DENSITY POLYETHYLENE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharmaceuticals Inc | nystatin and triamcinolone acetonide | 64980-325 |
| >Company | >Ingredient | >NDC |
nystatin and triamcinolone acetonide drug variants not containing LOW DENSITY POLYETHYLENE
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
nystatin and triamcinolone acetonide drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | nystatin and triamcinolone acetonide | 13668-610 |
| >Company | >Ingredient | >NDC |
nystatin and triamcinolone acetonide drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Excipient focus: METHYLPARABEN
nystatin and triamcinolone acetonide drug variants containing METHYLPARABEN
nystatin and triamcinolone acetonide drug variants not containing METHYLPARABEN
Excipient focus: MINERAL OIL
nystatin and triamcinolone acetonide drug variants containing MINERAL OIL
nystatin and triamcinolone acetonide drug variants not containing MINERAL OIL
Excipient focus: PEG-8 STEARATE
nystatin and triamcinolone acetonide drug variants containing PEG-8 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | nystatin and triamcinolone acetonide | 43598-431 |
| Aleor Dermaceuticals Limited | nystatin and triamcinolone acetonide | 71589-012 |
| >Company | >Ingredient | >NDC |
nystatin and triamcinolone acetonide drug variants not containing PEG-8 STEARATE
Excipient focus: PETROLATUM
nystatin and triamcinolone acetonide drug variants containing PETROLATUM
nystatin and triamcinolone acetonide drug variants not containing PETROLATUM
Excipient focus: POLAWAX POLYSORBATE
nystatin and triamcinolone acetonide drug variants containing POLAWAX POLYSORBATE
| Company | Ingredient | NDC |
|---|---|---|
| Crown Laboratories | nystatin and triamcinolone acetonide | 0316-0223 |
| REMEDYREPACK INC | nystatin and triamcinolone acetonide | 70518-2935 |
| >Company | >Ingredient | >NDC |
nystatin and triamcinolone acetonide drug variants not containing POLAWAX POLYSORBATE
Excipient focus: POLYETHYLENE GLYCOL 400
nystatin and triamcinolone acetonide drug variants containing POLYETHYLENE GLYCOL 400
nystatin and triamcinolone acetonide drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYOXYL 20 CETOSTEARYL ETHER
nystatin and triamcinolone acetonide drug variants containing POLYOXYL 20 CETOSTEARYL ETHER
nystatin and triamcinolone acetonide drug variants not containing POLYOXYL 20 CETOSTEARYL ETHER
Excipient focus: POLYOXYL 8 STEARATE
nystatin and triamcinolone acetonide drug variants containing POLYOXYL 8 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | nystatin and triamcinolone acetonide | 13668-610 |
| Alembic Pharmaceuticals Inc | nystatin and triamcinolone acetonide | 62332-606 |
| Lupin Pharmaceuticals Inc | nystatin and triamcinolone acetonide | 68180-545 |
| >Company | >Ingredient | >NDC |
nystatin and triamcinolone acetonide drug variants not containing POLYOXYL 8 STEARATE
Excipient focus: POLYSORBATE 60
nystatin and triamcinolone acetonide drug variants containing POLYSORBATE 60
nystatin and triamcinolone acetonide drug variants not containing POLYSORBATE 60
Excipient focus: POTASSIUM SORBATE
nystatin and triamcinolone acetonide drug variants containing POTASSIUM SORBATE
| Company | Ingredient | NDC |
|---|---|---|
| Crown Laboratories | nystatin and triamcinolone acetonide | 0316-0223 |
| REMEDYREPACK INC | nystatin and triamcinolone acetonide | 70518-2935 |
| >Company | >Ingredient | >NDC |
nystatin and triamcinolone acetonide drug variants not containing POTASSIUM SORBATE
Excipient focus: PROPYLENE GLYCOL
nystatin and triamcinolone acetonide drug variants containing PROPYLENE GLYCOL
nystatin and triamcinolone acetonide drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
nystatin and triamcinolone acetonide drug variants containing PROPYLPARABEN
nystatin and triamcinolone acetonide drug variants not containing PROPYLPARABEN
Excipient focus: SILICON DIOXIDE
nystatin and triamcinolone acetonide drug variants containing SILICON DIOXIDE
nystatin and triamcinolone acetonide drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM HYDROXIDE
nystatin and triamcinolone acetonide drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | nystatin and triamcinolone acetonide | 0168-0081 |
| >Company | >Ingredient | >NDC |
nystatin and triamcinolone acetonide drug variants not containing SODIUM HYDROXIDE
Excipient focus: SORBIC ACID
nystatin and triamcinolone acetonide drug variants containing SORBIC ACID
nystatin and triamcinolone acetonide drug variants not containing SORBIC ACID
Excipient focus: SORBITOL
nystatin and triamcinolone acetonide drug variants containing SORBITOL
nystatin and triamcinolone acetonide drug variants not containing SORBITOL
Excipient focus: TITANIUM DIOXIDE
nystatin and triamcinolone acetonide drug variants containing TITANIUM DIOXIDE
nystatin and triamcinolone acetonide drug variants not containing TITANIUM DIOXIDE
Excipient focus: WATER
nystatin and triamcinolone acetonide drug variants containing WATER
nystatin and triamcinolone acetonide drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
